NASDAQ: PHVSPharvaris Nv Stock Ownership - Who owns Pharvaris Nv?
Insider buying vs selling
Have Pharvaris Nv insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Robert Glassman | Director | 2026-09-15 | 8,667 | $22.31 | $193.36kBuy |
| Stefan Andreas Abele | CTO | 2026-09-15 | 45,000 | $16.40 | $738.00kBuy |
| Stefan Andreas Abele | CTO | 2026-09-15 | 45,000 | $38.14 | $1.72MSell |
| Stefan Andreas Abele | CTO | 2026-09-15 | 1,400 | $39.24 | $54.94kSell |
| Wim Souverijns | CCO | 2026-09-15 | 6,090 | $38.99 | $237.45kSell |
| Robert Glassman | Director | 2026-09-15 | 8,667 | $38.27 | $331.71kSell |
| Wim Souverijns | CCO | 2026-09-14 | 20,000 | $17.43 | $348.60kBuy |
| Peng Lu | Pres | 2026-09-14 | 117 | $38.02 | $4.45kSell |
| Berndt Modig | CEO | 2026-09-14 | 2,291 | $39.41 | $90.28kSell |
| Wim Souverijns | CCO | 2026-09-14 | 20,000 | $39.31 | $786.12kSell |
PHVS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PHVS insiders and whales buy or sell their stock.
PHVS Shareholders
What type of owners hold Pharvaris Nv stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Berndt Modig | 4.24% | 2,978,334 | $113.18M | Insider |
| Anne Lesage | 0.86% | 605,226 | $23.00M | Insider |
| Johannes Gerardus Christiaan Petrus Schikan | 0.45% | 315,167 | $11.98M | Insider |
| David W. Nassif | 0.17% | 120,300 | $4.57M | Insider |
| Annick Deschoolmeester | 0.13% | 92,553 | $3.52M | Insider |
| David P. Meeker | 0.09% | 65,167 | $2.48M | Insider |
| Peng Lu | 0.09% | 64,953 | $2.47M | Insider |
| Anna Nijdam | 0.07% | 46,275 | $1.76M | Insider |
| Stefan Andreas Abele | 0.06% | 39,068 | $1.48M | Insider |
| Wim Souverijns | 0.06% | 39,021 | $1.48M | Insider |
PHVS vs Biotech Stocks
Pharvaris Nv Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.